AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 82 filers reported holding AVADEL PHARMACEUTICALS PLC in Q2 2020. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $75,000 | -43.6% | 11,299 | -57.1% | 0.01% | -42.9% |
| Q3 2020 | $133,000 | -62.5% | 26,321 | -40.1% | 0.02% | -60.4% |
| Q2 2020 | $355,000 | +373.3% | 43,919 | +256.8% | 0.05% | +381.8% |
| Q2 2018 | $75,000 | -53.4% | 12,310 | -37.5% | 0.01% | -62.1% |
| Q4 2017 | $161,000 | -21.5% | 19,697 | +1.1% | 0.03% | -12.1% |
| Q3 2017 | $205,000 | – | 19,491 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Broadfin Capital, LLC | 3,102,673 | $4,468,000 | 0.92% |
| JW Asset Management, LLC | 444,439 | $640,000 | 0.33% |
| BRANDES INVESTMENT PARTNERS, LP | 7,052,720 | $10,157,000 | 0.24% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,722,241 | $3,920,000 | 0.15% |
| Tekla Capital Management LLC | 814,588 | $1,173,000 | 0.05% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 34,750 | $50,000 | 0.04% |
| Brown Capital Management | 1,400,007 | $2,016,000 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 843,975 | $1,217,000 | 0.01% |
| WEDBUSH SECURITIES INC | 35,535 | $51,000 | 0.01% |
| Close Asset Management Ltd | 15,000 | $22,000 | 0.00% |